These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 23537870)
1. Breakthrough Streptococcus pneumoniae type 6B infection after adrenocorticotropic hormone therapy in a child vaccinated with pneumococcal conjugate vaccine. Lee MH; Lu CY; Hsueh PR; Shao PL; Chang LY; Lee PI; Huang LM J Formos Med Assoc; 2013 Apr; 112(4):230-2. PubMed ID: 23537870 [TBL] [Abstract][Full Text] [Related]
2. The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children. Thanee C; Pancharoen C; Likitnukul S; Luangwedchakarn V; Umrod P; Phasomsap C; Apornpong T; Chuanchareon T; Butterworth O; Puthanakit T Vaccine; 2011 Aug; 29(35):5886-91. PubMed ID: 21729732 [TBL] [Abstract][Full Text] [Related]
3. Invasive pneumococcal infections among vaccinated children in the United States. Park SY; Van Beneden CA; Pilishvili T; Martin M; Facklam RR; Whitney CG; J Pediatr; 2010 Mar; 156(3):478-483.e2. PubMed ID: 19962156 [TBL] [Abstract][Full Text] [Related]
5. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. Klugman KP; Madhi SA; Huebner RE; Kohberger R; Mbelle N; Pierce N; N Engl J Med; 2003 Oct; 349(14):1341-8. PubMed ID: 14523142 [TBL] [Abstract][Full Text] [Related]
6. Bacterial Meningitis Due to Streptococcus pneumoniae in a 7-Month-Old Girl Who Received Three Doses of 13-Valent Pneumococcal Conjugate Vaccine. Yoshida K; Narazaki H; Okada H; Takagi A; Itoh Y J Nippon Med Sch; 2020; 87(5):299-303. PubMed ID: 33311009 [TBL] [Abstract][Full Text] [Related]
7. [Serious invasive pneumococcal disease in young children: the importance of vaccination]. Haveman LM; Geelen SP; Sanders EA; Wolfs TF Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1917-20. PubMed ID: 12404904 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases. Rivera-Olivero IA; Del Nogal B; Fuentes M; Cortez R; Bogaert D; Hermans PW; Waard JH Vaccine; 2014 Jun; 32(31):4006-11. PubMed ID: 24837505 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Taiwan. Lin TY; Lu CY; Chang LY; Chiu CH; Huang YC; Bock HL; Tang H; François N; Moreira M; Schuerman L; Huang LM J Formos Med Assoc; 2012 Sep; 111(9):495-503. PubMed ID: 23021506 [TBL] [Abstract][Full Text] [Related]
11. The safety of 7-valent pneumococcal conjugate vaccine. Ghaffar F Expert Opin Drug Saf; 2005 Jul; 4(4):631-6. PubMed ID: 16011442 [TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada. Vanderkooi OG; Scheifele DW; Girgenti D; Halperin SA; Patterson SD; Gruber WC; Emini EA; Scott DA; Kellner JD; Pediatr Infect Dis J; 2012 Jan; 31(1):72-7. PubMed ID: 21960186 [TBL] [Abstract][Full Text] [Related]
13. Recurrent invasive pneumococcal disease in children--host factors and vaccination response. Ingels HA Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055 [TBL] [Abstract][Full Text] [Related]
14. [Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk]. de Greeff SC; Sanders EA; de Melker HE; van der Ende A; Vermeer PE; Schouls LM Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1454-7. PubMed ID: 17633974 [TBL] [Abstract][Full Text] [Related]
15. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait. Mokaddas E; Albert MJ Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356 [TBL] [Abstract][Full Text] [Related]
16. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490 [TBL] [Abstract][Full Text] [Related]
17. Pneumococcal conjugate vaccine for young children. Selman S; Hayes D; Perin LA; Hayes WS Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663 [TBL] [Abstract][Full Text] [Related]
18. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine. Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035 [TBL] [Abstract][Full Text] [Related]
19. Vaccinate your child and save its grandparents from a heart attack? Current perspectives in antipneumococcal vaccination. Vila-Córcoles A J Intern Med; 2009 Nov; 266(5):432-44. PubMed ID: 19754854 [TBL] [Abstract][Full Text] [Related]
20. [Disribution of Streptococcus pneumoniae serotypes and serogroups among patients with invasive pneumococcal diseases in the Czech Republic in 1996-2003: background data for vaccination strategy]. Motlová J Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):3-10. PubMed ID: 15807381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]